AURO LABORATORIES
|
The Current P/E Ratio of AURO LABORATORIES is 55.78.
| Share Price | ₹266.0 | Apr 06,2026 |
| Market Cap | ₹164.9 Cr | |
| Earnings-TTM | ₹3.0 Cr | TTM-Standalone Results |
| Price/Earnings | 55.78x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of AURO LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹164.9 Cr] as on Apr 06,2026
(/) Earnings [ ₹3.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 55.78x ]
Thus, for AURO LABORATORIES , the investors are currently willing to pay 55.78 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AURO LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of AURO LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of AURO LABORATORIES
PE Ratio Performance Analysis for AURO LABORATORIES
- AURO LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 26.80x.
- AURO LABORATORIES 's operated at median p/e ratio of 13.95x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AURO LABORATORIES 's p/e ratio peaked in Mar2025 at 78.15x.
- AURO LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 7.04x.
How does AURO LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| AURO LABORATORIES | 2.96 | 55.78 | 164.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 36.95 | 406,495.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 62.22 | 154,244.0 |
| CIPLA LTD | 4,544.70 | 21.35 | 97,022.8 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 59.70 | 135,634.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 18.44 | 101,594.0 |
| MANKIND PHARMA LTD | 1,796.65 | 46.39 | 83,352.1 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 17.67 | 87,175.1 |
| LUPIN LTD | 4,669.18 | 22.30 | 104,141.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 22.15 | 77,815.8 |
| ABBOTT INDIA LTD | 1,524.13 | 36.12 | 55,059.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AURO LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.67x |
| Max industry PE | 62.22x |
| Median industry PE | 36.12x |
| Average industry PE | 36.28x |
You may also like the below Video Courses